SEC 13F Intelligence

Cheyne Capital Management (UK) LLP / PCVX

Cheyne Capital Management (UK) LLP’s Vaxcyte Inc Position

Does Cheyne Capital Management (UK) LLP own Vaxcyte Inc (PCVX)? Not currently — the last reported position was 26.8K shares worth $1M in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$1M
Q4 2022
Shares
26.8K
% of Portfolio
+2.25%
Quarters Held
1
position exited

Position History PCVX

Reported value by quarter
Q4 ’22: $1MQ4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202226.8K$1M+2.25%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cheyne Capital Management (UK) LLP’s full portfolio or all institutional holders of PCVX.